Evidence-based medicine has been hijacked: a report to David Sackett

被引:158
作者
Ioannidis, John P. A. [1 ,2 ,3 ,4 ]
机构
[1] Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
[4] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
关键词
NEEDS; GUIDELINES; TRIALS;
D O I
10.1016/j.jclinepi.2016.02.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This is a confession building on a conversation with David Sackett in 2004 when I shared with him some personal adventures in evidence based medicine (EBM), the movement that he had spearheaded. The narrative is expanded with what ensued in the subsequent 12 years. EBM has become far more recognized and adopted in many places, but not everywhere, for example, it never acquired much influence in the USA. As EBM became more influential, it was also hijacked to serve agendas different from what it originally aimed for. Influential randomized trials are largely done by and for the benefit of the industry. Meta-analyses and guidelines have become a factory, mostly also serving vested interests. National and federal research funds are funneled almost exclusively to research with little relevance to health outcomes. We have supported the growth of principal investigators who excel primarily as managers absorbing more money. Diagnosis and prognosis research and efforts to individualize treatment have fueled recurrent spurious promises. Risk factor epidemiology has excelled in salami-sliced data-dredged articles with gift authorship and has become adept to dictating policy from spurious evidence. Under market pressure, clinical medicine has been transformed to finance-based medicine. In many places, medicine and health care are wasting societal resources and becoming a threat to human well-being. Science denialism and quacks are also flourishing and leading more people astray in their life choices, including health. EBM still remains an unmet goal, worthy to be attained. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:82 / 86
页数:5
相关论文
共 40 条
  • [1] Compliance with Results Reporting at ClinicalTrials.gov
    Anderson, Monique L.
    Chiswell, Karen
    Peterson, Eric D.
    Tasneem, Asba
    Topping, James
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) : 1031 - 1039
  • [2] False-positive results in cancer epidemiology: A plea for epistemological modesty
    Boffetta, Paolo
    McLaughlin, Joseph K.
    La Vecchia, Carlo
    Tarone, Robert E.
    Lipworth, Loren
    Blot, William J.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (14): : 988 - 995
  • [3] Caulfield T, 2015, Is Gwyneth Paltrow Wrong About Everything? When Celebrity Culture and Science Clash
  • [4] Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review
    Contopoulos-Ioannidis, Despina G.
    Ioannidis, John P. A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (03) : 233 - 244
  • [5] David L, 2016, SACKETT INTERVIEW 20
  • [6] Meta-analyses with industry involvement are massively published and report no caveats for antidepressants
    Ebrahim, Shanil
    Bance, Sheena
    Athale, Abha
    Malachowski, Cindy
    Ioannidis, John P. A.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 70 : 155 - 163
  • [7] How evidence-based medicine is failing due to biased trials and selective publication
    Every-Palmer, Susanna
    Howick, Jeremy
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2014, 20 (06) : 908 - 914
  • [8] Arabian nights-1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report
    Giannakakis, IA
    Ioannidis, JPA
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7276) : 1563 - 1564
  • [9] Too much medicine; too little care
    Glasziou, Paul
    Moynihan, Ray
    Richards, Tessa
    Godlee, Fiona
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [10] Ghost authorship in industry-initiated randomised trials
    Gotzsche, Peter C.
    Hrobjartsson, Asbjorn
    Johansen, Helle Krogh
    Haahr, Mette T.
    Altman, Douglas G.
    Chan, An-Wen
    [J]. PLOS MEDICINE, 2007, 4 (01): : 47 - 52